13 October 2020
: Case report 
An Autopsy Case of TAFRO Syndrome with Type II Respiratory Failure
Rare disease
Mikio Wada1ABCDEF*, Akihiro Nagata2BCDE, Atsushi Kawashima3ABCDEF, Keizo Kagawa3DEFDOI: 10.12659/AJCR.926721
Am J Case Rep 2020; 21:e926721
Table 1. Laboratory findings on first admission.
| White blood cells (/μL) | 2950 |
| Red blood cells (×10/μL) | 343 |
| Hemoglobin (g/dL) | 10.4 |
| Hematocrit (%) | 33.3 |
| MCV (fL) | 97.1 |
| Platelet counts (×10/μL) | 4.3 |
| Albumin (g/dL) | 3.3 |
| AST (IU/L) | 15 |
| ALT (IU/L) | 13 |
| LDH (IU/L) | 53 |
| ALP (IU/L) | 206 |
| BUN (mg/dL) | 50 |
| Creatinine (mg/dL) | 1.55 |
| eGFR (mL/min/1.73 m) | 37.2 |
| Na (mEq/L) | 137 |
| K (mEq/L) | 5.4 |
| CL (mEq/L) | 99 |
| IL-6 (pg/ml) | 4.97 |
| VEGF (pg/ml) | 151 |
| PT-T (sec) | 14.2 |
| PT-INR | 1.26 |
| APTT (sec) | 43.1 |
| FDP (μg/mL) | 3.9 |
| D-dimer (μg/mL) | 1.9 |
| CRP (mg/dL) | 0.17 |
| IgG (mg/dL) | 2168 |
| IgA (mg/dL) | 418 |
| IgM (mg/dL) | 39 |
| C3 (mg/dL) | 44 |
| C4 (mg/dL) | 17.7 |
| CH50 (IU/L) | 33 |
| Antinuclear antibody | Negative |
| Thyroglobulin antibody (IU/mL) | 495.7 |
| Thyroid peroxidase antibody (IU/mL) | 148.1 |
| PAIgG (ng/10 cells) | 20.9 |
| Acetylcholine receptor antibody | Negative |
| HHV-8 DNA PCR | Negative |
| Analysis of blood gases | |
| pH | 7.31 |
| pCO (mmHg) | 62 |
| pO (mmHg) | 58.5 |
| HCO (mmol/L) | 30.5 |
| Urine test | |
| Protein | +/– |
| Glucose | Negative |
| Urinary sediment | |
| RBC (/HPF) | 1–4 |
| WBC (/HPF) | <1 |
| AST – aspartate aminotransferase; ALT – alanine aminotransferase; LDH – lactate dehydrogenase; ALP – alkaline phosphatase; VFGF – vascular endothelial growth factor; PAIgG – platelet-associated IgG; HHV-8 – human herpes virus 8. | |